Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Author Correction: Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA).
Graier T, Weger W, Jonak C, Sator P, Zikeli C, Prillinger K, Sassmann C, Gruber B, Saxinger W, Ratzinger G, Painsi C, Mlynek A, Häring N, Sadoghi B, Trattner H, Müllegger R, Quehenberger F, Salmhofer W, Wolf P. Graier T, et al. Sci Rep. 2024 Mar 26;14(1):7144. doi: 10.1038/s41598-024-57807-3. Sci Rep. 2024. PMID: 38532006 Free PMC article. No abstract available.
Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert Network.
Wolf P, Ceovic R, Conrad C, Falkensteiner K, Graier T, Kołt-Kamińska M, Marovt M, Mateeva V, Maul JT, Navarini AA, Nicolescu AC, Ratzinger G, Pavlovsky L, Sanzharovskaya M, Szegedi A, Reich A. Wolf P, et al. Among authors: graier t. J Eur Acad Dermatol Venereol. 2024 Jan 27. doi: 10.1111/jdv.19808. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38279888
[Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022].
Graier T, Salmhofer W, Jonak C, Weger W, Zikeli C, Gruber B, Sator P, Prillinger K, Mlynek A, Schütz-Bergmayr M, Richter L, Ratzinger G, Sassmann C, Painsi C, Häring N, Wippel-Slupetzky K, Skvara H, Trattner H, Inzinger M, Bangert C, Ellersdorfer C, Falkensteiner K, Sadoghi B, Gruber-Wackernagel A, Hofer A, Legat F, Lange-Asschenfeldt B, Schmuth M, Vujic I, Hötzenecker W, Saxinger W, Müllegger R, Quehenberger F, Wolf P. Graier T, et al. J Dtsch Dermatol Ges. 2023 Dec;21(12):1513-1523. doi: 10.1111/ddg.15213_g. J Dtsch Dermatol Ges. 2023. PMID: 38082521 German.
Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022.
Graier T, Salmhofer W, Jonak C, Weger W, Zikeli C, Gruber B, Sator P, Prillinger K, Mlynek A, Schütz-Bergmayr M, Richter L, Ratzinger G, Sassmann C, Painsi C, Häring N, Wippel-Slupetzky K, Skvara H, Trattner H, Inzinger M, Bangert C, Ellersdorfer C, Falkensteiner K, Sadoghi B, Gruber-Wackernagel A, Hofer A, Legat F, Lange-Asschenfeldt B, Schmuth M, Vujic I, Hötzenecker W, Saxinger W, Müllegger R, Quehenberger F, Wolf P. Graier T, et al. J Dtsch Dermatol Ges. 2023 Dec;21(12):1513-1523. doi: 10.1111/ddg.15213. Epub 2023 Oct 31. J Dtsch Dermatol Ges. 2023. PMID: 37907427
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
Sorger H, Dey S, Vieyra-Garcia PA, Pölöske D, Teufelberger AR, de Araujo ED, Sedighi A, Graf R, Spiegl B, Lazzeri I, Braun T, Garces de Los Fayos Alonso I, Schlederer M, Timelthaler G, Kodajova P, Pirker C, Surbek M, Machtinger M, Graier T, Perchthaler I, Pan Y, Fink-Puches R, Cerroni L, Ober J, Otte M, Albrecht JD, Tin G, Abdeldayem A, Manaswiyoungkul P, Olaoye OO, Metzelder ML, Orlova A, Berger W, Wobser M, Nicolay JP, André F, Nguyen VA, Neubauer HA, Fleck R, Merkel O, Herling M, Heitzer E, Gunning PT, Kenner L, Moriggl R, Wolf P. Sorger H, et al. Among authors: graier t. EMBO Mol Med. 2022 Dec 7;14(12):e15200. doi: 10.15252/emmm.202115200. Epub 2022 Nov 7. EMBO Mol Med. 2022. PMID: 36341492 Free PMC article.
Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA).
Graier T, Weger W, Jonak C, Sator P, Zikeli C, Prillinger K, Sassmann C, Gruber B, Saxinger W, Ratzinger G, Painsi C, Mlynek A, Häring N, Sadoghi B, Trattner H, Müllegger R, Quehenberger F, Salmhofer W, Wolf P. Graier T, et al. Sci Rep. 2022 Sep 5;12(1):15078. doi: 10.1038/s41598-022-18790-9. Sci Rep. 2022. PMID: 36064563 Free PMC article.
Pityriasis rosea in pregnancy: A case series and literature review.
Wenger-Oehn L, Graier T, Ambros-Rudolph C, Müllegger R, Bittighofer C, Wolf P, Hofer A. Wenger-Oehn L, et al. Among authors: graier t. J Dtsch Dermatol Ges. 2022 Jul;20(7):953-959. doi: 10.1111/ddg.14763. Epub 2022 May 26. J Dtsch Dermatol Ges. 2022. PMID: 35616213 Free PMC article. Review.
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis.
Graier T, Weger W, Sator PG, Salmhofer W, Gruber B, Jonak C, Kölli C, Schütz-Bergmayr M, Vujic I, Ratzinger G, Häring N, Painsi C, Prillinger K, Mlynek A, Skvara H, Trattner H, Tanew A, Lichem R, Ellersdorfer C, Legat F, Gruber-Wackernagel A, Hofer A, Schmiedberger E, Hoetzenecker W, Müllegger R, Saxinger W, Quehenberger F, Wolf P. Graier T, et al. JAAD Int. 2020 Dec 26;2:62-75. doi: 10.1016/j.jdin.2020.10.012. eCollection 2021 Mar. JAAD Int. 2020. PMID: 34409355 Free PMC article.
16 results